Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 25,968 shares at $79.96 ($2.1M) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $2.1M GILD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.96 | 12,984 | $1.0M | 50.0% |
| 2 | $79.96 | 12,984 | $1.0M | 50.0% |
| Total | $79.96 avg | 25,968 | $2.1M | 100% |
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |